
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1142 | 1005 | 1142 | 1269 | 1321 | 1650 |
Fund Return | 14.2% | 0.48% | 14.2% | 8.25% | 5.72% | 5.13% |
Place in category | 339 | 153 | 339 | 55 | 85 | 171 |
% in Category | 54 | 19 | 54 | 9 | 19 | 50 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SSgA Luxembourg SICAV State Streewe | 4.71B | -6.48 | 8.52 | 9.27 | ||
State Street US Index EqI EUR Hdgd | 1.56B | -5.57 | 5.47 | 9.38 | ||
SSgA Luxembourg SICAV State Streete | 1.56B | -9.33 | 9.17 | 11.52 | ||
SSgA Enhanced EM Equity Fund I EUR | 619.38M | 4.07 | 5.77 | 5.35 | ||
State Street Europe Enhanced Equity | 325.37M | 11.67 | 10.89 | 6.05 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
United Kingdom Fund X2e | 188.25Array | 1.06 | 6.16 | 7.46 | ||
BlackRock UK Fund E2 EUR | 21.09M | 0.48 | 3.75 | 5.04 | ||
BlackRock Glbl Funds UK Fund A2 EUR | 84.4M | 0.61 | 4.27 | 5.57 | ||
BlackRock Glbl Funds UK Fund D2 EUR | 18.8M | 0.80 | 5.05 | 6.37 | ||
BlackRock Glbl Funds UK Fund C2 EUR | 3.21M | 0.30 | 2.97 | 4.26 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 9.15 | 10,008.0 | -0.10% | |
Shell | GB00BP6MXD84 | 8.66 | 26.79 | -1.51% | |
HSBC | GB0005405286 | 8.06 | 743.50 | +1.34% | |
Unilever | GB00B10RZP78 | 6.38 | 53.90 | +1.70% | |
Relx | GB00B2B0DG97 | 3.82 | 3,737.00 | +0.11% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Neutral |
Technical Indicators | Strong Sell | Sell | Neutral |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review